DUBLIN--(BUSINESS WIRE)--The "Global Antimicrobial Coatings Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
Antimicrobial Coatings Market was valued at $121.0 million in 2016, and is estimated to reach $345.5 million by 2023, growing at a CAGR of 16.3% during the forecast period.
Antibacterial coatings are overlay materials that restrict the growth of bacteria on the implants surface. Medical implants which are inserted internally have the potential to introduce bacterial infections; therefore, the need to replace the implants arises. Frequent replacement of implants would lead to excessive discomfort among patients; therefore, to prevent the bacterial infection, the medical implants are treated with antibacterial agents, which are biocompatible, bio-stable, and nontoxic.
The Antimicrobial coatings are segmented into metallic coatings & non-metallic coatings. Metallic coatings are further sub segmented into silver coatings, copper coatings, and other metallic coatings. The non-metallic coatings are further segmented into polymeric coatings and organic coatings.
Scope of the Report
- Based on material, the market report segments the market into metallic coating and non-metallic coating.
- Metallic coating further sub segmented into Silver Coatings, Copper Coatings, and Other Coatings (Zinc and Titanium coatings).
- Non-metallic coating is further divided into Polymeric Coatings and Organic Coatings.
The Type covered under the report includes Orthopedic Implants, Dental
Implants, Neurovascular Implants, Cardiac Implants, and Others.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Global Antimicrobial Coatings Market
Chapter 4. Global Antimicrobial Coatings Market by Type
Chapter 5. Global Antimicrobial Coatings Market by Region
Chapter 6. Company Profiles
- aap Implantate AG
- AST Products, Inc.
- Specialty Coating Systems, Inc.
- Sciessent LLC
- BioCote Limited
- Sciessent LLC
- Covalon Technologies Ltd.
- DOT GmbH
- Koninklijke DSM N.V.
- Hydromer Inc.
- Harland Medical Systems, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/t3dtmr/global?w=4